(Q41485282)

1 October 2017

1 reference

title

Tissue xenografts as a model system for study of the pathogenesis of papillomaviruses (English)

1 reference

1 October 2017

1 reference

Howett MK

1

1 reference

1 October 2017

Christensen ND

series ordinal

2

1 reference

1 October 2017

Kreider JW

series ordinal

3

1 reference

1 October 2017

publication date

1 March 1997

1 reference

1 October 2017

published in

Clinics in Dermatology

1 reference

1 October 2017

volume

15

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

229-236

1 reference

IMMUNIZATION OF RABBITS TO INFECTIOUS PAPILLOMATOSIS.

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Immunology of papillomavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Serological studies in a student population prone to infection with human papilloma virus

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Seroepidemiological studies of human papilloma virus (HPV-1) infections

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Incidence of antibodies to human papillomavirus type 1 in patients with cutaneous and mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP)

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Recent Progress in Defining the Epidemiology of Human Papillomavirus Infection and Cervical Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Determinants of genital human papillomavirus infection in low-income women in Washington, D.C.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Evaluation of Seroreactivity to Human Papillomavirus Type 16 Virus-like Particles in an Incident Case-Control Study of Cervical Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Rare association of human papillomavirus DNA with esophageal cancer in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Serological response to HPV16 in CIN-III and cervical-cancer patients. Case-control studies in Spain and Colombia

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Molecular and serological studies of human papillomavirus among patients with anal epidermoid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Serum antibody against unfused recombinant E7 protein of human papillomavirus type 16 in cervical cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Follow-up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Human papillomavirus-specific serologic response in vulvar neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Antibodies to human papillomavirus type 11 virus-like particles in sera of patients with genital warts and in control groups

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Epidemiology of genital human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Divergent human papillomavirus type 16 variants are serologically cross-reactive.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Antibody-Mediated Neutralization of Human Papillomavirus Type 11 (HPV-11) Infection in the Nude Mouse: Detection of HPV-11 mRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2896%2900166-6

7 January 2021

10.1016/S0738-081X(96)00166-6

Identifiers

DOI

1 reference

1 October 2017

1 reference